News for MannKind Corporation (NNFN.MU)

WESTLAKE VILLAGE, Calif., March 02, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of

WESTLAKE VILLAGE, Calif., March 02, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) today announced the pricing of $200.0 million aggregate

Today's Daily Dose brings you news about the regulatory set back of Athenex's oral Paclitaxel and CorMedix's Defencath, ASLAN Pharma's Atopic Dermatitis trial results, FDA panel review of FibroGen's Roxadustat, Morphic Therapeutic's Phase 1 single ascending dose clinical trial of MORF-057, which is in development for the treatment of inflammatory bowel disease, and STRATA Skin's CEO transition.

The following slide deck was published by MannKind Corporation in conjunction with their 2020 Q4 earnings call.

MannKind Corporation (NASDAQ:MNKD) Q4 2020 Earnings Conference Call Feb 25, 2020, 09:00 AM ET Company Participants Michael Castagna - CEO Steven Binder - CFO Conference Call Participants...

WESTLAKE VILLAGE, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of

WESTLAKE VILLAGE, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company...

Want to learn how to invest in tech stocks? Here's what to look for in a good tech investment and common tech investing mistakes to avoid.

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 3) 9 ...

Midstates Petroleum Co Inc is in the business of oil and natural gas exploration and production. The company focuses on the application of drilling and completi...